Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 7.14
+0.01 (0.14%)
Jun 15, 2026, 3:29 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 357.72 million as of June 15, 2026. Its market cap has decreased by -57.78% in one year.
Market Cap
357.72M
Enterprise Value
448.23M
Revenue
253.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.14
Market Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 357.72M, a decrease of -89.88%. That is a compound annual growth rate of -23.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 357.72M | -24.36% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 14.14B |
| Sigachi Industries | 7.89B |
| Bafna Pharmaceuticals | 3.91B |
| Valiant Laboratories | 3.64B |
| Nectar Lifesciences | 2.25B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.47B |
| Balaxi Pharmaceuticals | 1.26B |